SwipeRx (formerly mClinica Pharmacy Solutions), Southeast Asia's (SEA) leading platform for pharmacies, announced it has secured a Series B round of $27 million in equity and debt to accelerate growth across SEA.

The round was led by Indonesia's MDI Ventures, with participation from global investors, Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG and existing investors.

Singapore-based mClinica Pharmacy Solutions recently rebranded to SwipeRx, the name of its flagship app and has acquired more than 235,000 pharmacy professionals and 45,000 pharmacies across SEA to-date.

With a strong presence across Indonesia, The Philippines, Vietnam, Malaysia, Thailand and Cambodia, SwipeRx is ready to grow its network of pharmacies, expand their specialised healthcare logistics to fulfil B2B commerce, accelerate technological innovation and recruit talent across SEA.

SwipeRx sees vast opportunities to expand its community and commerce solutions for pharmacies across SEA and build on its lead in its key markets. With a strong team of over 400 employees, SwipeRx is poised to grow and scale across SEA.